Molecular and clinical determinants of response and resistance to rucaparib for recurrent ovarian cancer treatment in ARIEL2 (Parts 1 and 2)
ARIEL2 研究中复发性卵巢癌患者对 rucaparib 治疗的反应和耐药性的分子和临床决定因素(第 1 部分和第 2 部分)
期刊:Nature Communications
影响因子:15.7
doi:10.1038/s41467-021-22582-6
Swisher, Elizabeth M; Kwan, Tanya T; Oza, Amit M; Tinker, Anna V; Ray-Coquard, Isabelle; Oaknin, Ana; Coleman, Robert L; Aghajanian, Carol; Konecny, Gottfried E; O'Malley, David M; Leary, Alexandra; Provencher, Diane; Welch, Stephen; Chen, Lee-May; Wahner Hendrickson, Andrea E; Ma, Ling; Ghatage, Prafull; Kristeleit, Rebecca S; Dorigo, Oliver; Musafer, Ashan; Kaufmann, Scott H; Elvin, Julia A; Lin, Douglas I; Chambers, Setsuko K; Dominy, Erin; Vo, Lan-Thanh; Goble, Sandra; Maloney, Lara; Giordano, Heidi; Harding, Thomas; Dobrovic, Alexander; Scott, Clare L; Lin, Kevin K; McNeish, Iain A